Upgrade to SI Premium - Free Trial

FDA Approves Durvalumab in Combination with Bacillus Calmette-Guerin for High-Risk Non-Muscle Invasive Bladder Cancer

May 28, 2026 12:42 PM
FDA Approves Durvalumab in Combination with Bacillus ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA